Inhibition of lymphangiogenesis with resulting lymphedema in transgenic mice expressing soluble VEGF receptor-3.
The lymphatic vasculature transports extravasated tissue fluid, macromolecules and cells back into the blood circulation. Recent reports have focused on the molecular mechanisms regulating the lymphatic vessels. Vascular endothelial growth factor (VEGF)-C and VEGF-D have been shown to stimulate lymp...
| Hlavní autoři: | , , , , , , , , , , , |
|---|---|
| Médium: | Journal article |
| Jazyk: | English |
| Vydáno: |
2001
|
| _version_ | 1826283052240732160 |
|---|---|
| author | Mäkinen, T Jussila, L Veikkola, T Karpanen, T Kettunen, M Pulkkanen, K Kauppinen, R Jackson, D Kubo, H Nishikawa, S Ylä-Herttuala, S Alitalo, K |
| author_facet | Mäkinen, T Jussila, L Veikkola, T Karpanen, T Kettunen, M Pulkkanen, K Kauppinen, R Jackson, D Kubo, H Nishikawa, S Ylä-Herttuala, S Alitalo, K |
| author_sort | Mäkinen, T |
| collection | OXFORD |
| description | The lymphatic vasculature transports extravasated tissue fluid, macromolecules and cells back into the blood circulation. Recent reports have focused on the molecular mechanisms regulating the lymphatic vessels. Vascular endothelial growth factor (VEGF)-C and VEGF-D have been shown to stimulate lymphangiogenesis and their receptor, VEGFR-3, has been linked to human hereditary lymphedema. Here we show that a soluble form of VEGFR-3 is a potent inhibitor of VEGF-C/VEGF-D signaling, and when expressed in the skin of transgenic mice, it inhibits fetal lymphangiogenesis and induces a regression of already formed lymphatic vessels, though the blood vasculature remains normal. Transgenic mice develop a lymphedema-like phenotype characterized by swelling of feet, edema and dermal fibrosis. They survive the neonatal period in spite of a virtually complete lack of lymphatic vessels in several tissues, and later show regeneration of the lymphatic vasculature, indicating that induction of lymphatic regeneration may also be possible in humans. |
| first_indexed | 2024-03-07T00:53:06Z |
| format | Journal article |
| id | oxford-uuid:871297f7-813b-450e-932b-f47ea1092af0 |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-07T00:53:06Z |
| publishDate | 2001 |
| record_format | dspace |
| spelling | oxford-uuid:871297f7-813b-450e-932b-f47ea1092af02022-03-26T22:08:21ZInhibition of lymphangiogenesis with resulting lymphedema in transgenic mice expressing soluble VEGF receptor-3.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:871297f7-813b-450e-932b-f47ea1092af0EnglishSymplectic Elements at Oxford2001Mäkinen, TJussila, LVeikkola, TKarpanen, TKettunen, MPulkkanen, KKauppinen, RJackson, DKubo, HNishikawa, SYlä-Herttuala, SAlitalo, KThe lymphatic vasculature transports extravasated tissue fluid, macromolecules and cells back into the blood circulation. Recent reports have focused on the molecular mechanisms regulating the lymphatic vessels. Vascular endothelial growth factor (VEGF)-C and VEGF-D have been shown to stimulate lymphangiogenesis and their receptor, VEGFR-3, has been linked to human hereditary lymphedema. Here we show that a soluble form of VEGFR-3 is a potent inhibitor of VEGF-C/VEGF-D signaling, and when expressed in the skin of transgenic mice, it inhibits fetal lymphangiogenesis and induces a regression of already formed lymphatic vessels, though the blood vasculature remains normal. Transgenic mice develop a lymphedema-like phenotype characterized by swelling of feet, edema and dermal fibrosis. They survive the neonatal period in spite of a virtually complete lack of lymphatic vessels in several tissues, and later show regeneration of the lymphatic vasculature, indicating that induction of lymphatic regeneration may also be possible in humans. |
| spellingShingle | Mäkinen, T Jussila, L Veikkola, T Karpanen, T Kettunen, M Pulkkanen, K Kauppinen, R Jackson, D Kubo, H Nishikawa, S Ylä-Herttuala, S Alitalo, K Inhibition of lymphangiogenesis with resulting lymphedema in transgenic mice expressing soluble VEGF receptor-3. |
| title | Inhibition of lymphangiogenesis with resulting lymphedema in transgenic mice expressing soluble VEGF receptor-3. |
| title_full | Inhibition of lymphangiogenesis with resulting lymphedema in transgenic mice expressing soluble VEGF receptor-3. |
| title_fullStr | Inhibition of lymphangiogenesis with resulting lymphedema in transgenic mice expressing soluble VEGF receptor-3. |
| title_full_unstemmed | Inhibition of lymphangiogenesis with resulting lymphedema in transgenic mice expressing soluble VEGF receptor-3. |
| title_short | Inhibition of lymphangiogenesis with resulting lymphedema in transgenic mice expressing soluble VEGF receptor-3. |
| title_sort | inhibition of lymphangiogenesis with resulting lymphedema in transgenic mice expressing soluble vegf receptor 3 |
| work_keys_str_mv | AT makinent inhibitionoflymphangiogenesiswithresultinglymphedemaintransgenicmiceexpressingsolublevegfreceptor3 AT jussilal inhibitionoflymphangiogenesiswithresultinglymphedemaintransgenicmiceexpressingsolublevegfreceptor3 AT veikkolat inhibitionoflymphangiogenesiswithresultinglymphedemaintransgenicmiceexpressingsolublevegfreceptor3 AT karpanent inhibitionoflymphangiogenesiswithresultinglymphedemaintransgenicmiceexpressingsolublevegfreceptor3 AT kettunenm inhibitionoflymphangiogenesiswithresultinglymphedemaintransgenicmiceexpressingsolublevegfreceptor3 AT pulkkanenk inhibitionoflymphangiogenesiswithresultinglymphedemaintransgenicmiceexpressingsolublevegfreceptor3 AT kauppinenr inhibitionoflymphangiogenesiswithresultinglymphedemaintransgenicmiceexpressingsolublevegfreceptor3 AT jacksond inhibitionoflymphangiogenesiswithresultinglymphedemaintransgenicmiceexpressingsolublevegfreceptor3 AT kuboh inhibitionoflymphangiogenesiswithresultinglymphedemaintransgenicmiceexpressingsolublevegfreceptor3 AT nishikawas inhibitionoflymphangiogenesiswithresultinglymphedemaintransgenicmiceexpressingsolublevegfreceptor3 AT ylaherttualas inhibitionoflymphangiogenesiswithresultinglymphedemaintransgenicmiceexpressingsolublevegfreceptor3 AT alitalok inhibitionoflymphangiogenesiswithresultinglymphedemaintransgenicmiceexpressingsolublevegfreceptor3 |